期刊文献+

全胸腔镜全肺切除治疗非小细胞肺癌 被引量:14

Primary outcome of completely thoracoscopic pneumonectomy for non-smaU cell lung cancer
原文传递
导出
摘要 目的探讨全胸腔镜全肺切除在非小细胞肺癌手术治疗中的安全性和有效性。方法2009年1月至2012年6月共施行全胸腔镜下全肺切除术治疗非小细胞肺癌16例,年龄46~83岁,平均62.2岁。手术全部通过3个胸腔镜切口完成,不撑开肋间,完全在胸腔镜视野下使用腔镜器械进行解剖性全肺切除和系统性淋巴结清扫。结果全组手术过程顺利,未发生严重并发症,无围手术期死亡,无中转开胸病例。平均手术(174.6±52.7)min;无输血病例,术中平均出血(121.8±87.5)ml;每例清扫淋巴结平均(5.2±1.1)组,清扫淋巴结平均(16.0±3.2)个;术后平均胸腔闭式引流(4.2±1.8)天;术后平均住院(13.0±3.1)天。结论全胸腔镜下全肺切除治疗非小细胞肺癌安全可行,并未增加全肺切除术围手术期风险,值得总结经验并加以推广应用。 Objective To evaluate the feasibility and safety of the completely thoracoscopic pneumonectorny for non- small cell lung cancer (NSCLC), Methods From January 2009 to June 2012, 16 patients with NSCLC received completely thoraeoscopic pneumonectomy. Three incisions were made in the thoracoscopic pneumonectomy. Without softening the intercos- tal space, we used thoracoscopic equipment for anatomic lung resection under thoracoscopic vision totally and the sequence of operations of systematic lymph node dissection was basically the same as conventional thoracotomy. Evaluation indicators inclu- ding lymph node dissection, operation time, bleeding loss, time of drainage, pathological staging, hospitalization time, and postoperative complications. Results All 16 patients with non-small cell lung cancer were operated safely, without serious complications and death in the period of operation. There was no case of conversion to thoracotomy. The mean operation time was( 174.6 ± 52.7) minutes. There was no blood transfusion cases in the completely thoracoscopic group, whose blood loss is ( 121.8 -± 87.5 ) mh The mean groups of lymph nodes dissection was (5.2 _± 1.1 ) , The mean time of drainage was (4.2 ~ h 8 ) ,The mean hospitalization time was ( 13.0 ± 3.1 ). Conclusion Completely thoracoscopic pneumonectomy for non-small cell lung cancer should achieve the same objective of thoracotomy in terms of effectiveness and thoroughness. By no increasing perioperative risk, it is worth summarizing the experience of completely thoracoscopic pneumoneetomy for non-small cell lung cancer and promoting it to application.
出处 《中华胸心血管外科杂志》 CSCD 北大核心 2013年第1期1-3,共3页 Chinese Journal of Thoracic and Cardiovascular Surgery
基金 :2010年广东省医学科研基金(B2010004)
关键词 胸腔镜 肺切除术 非小细胞肺 Thoracoscopic Pneumonectomy Carcinoma, non-small-cell lung
作者简介 通信作者:陈刚Email:chenganggz@yahoo.cn
  • 相关文献

参考文献6

二级参考文献105

  • 1Robert J. McKenna,罗晓阳.肺癌微创治疗新技术现状——胸腔镜在肺癌治疗中的应用[J].中国癌症杂志,2005,15(3):209-212. 被引量:59
  • 2严秉泉,高启明,马振中,陈汉章.胸腔镜肺门解剖肺切除术的探讨[J].中华外科杂志,1996,34(2):69-72. 被引量:18
  • 3王俊,陈鸿义,崔英杰,刘桐林,李剑峰,李曰民.胸腔镜手术在肺癌诊断和治疗中的作用和地位[J].中华外科杂志,1996,34(2):79-81. 被引量:57
  • 4刘会平.微创肺叶切除术临床技巧[J].中国微创外科杂志,2006,6(9):646-647. 被引量:10
  • 5Swanson SJ, Herndon JE 2nd, D'Amico TA, et al. Video-assisted thoracic surgery lobectomy: report of CALGB 39802--A prospective, muhiinstitution feasibility study. J Clin Oncol, 2007, 25: 4993 - 4997.
  • 6Onaitis MW, Petersen RP, Balderson SS, et al. Thoracoscopic lobectomy is a safe and versatile procedure: experience with 500 consecutive patients. Ann Surg 2006,244:420 - 425.
  • 7McKenna RJ Jr, Houck W, Fuller CB. Video-assisted thoracic surgery lobectomy: experience with 1,100 cases. Ann Thorac Surg, 2006,81:421 -425.
  • 8Yan TD, Black DB, Paul G, et al. Systematic Review and meta-analysis of randomized and nonrandomized trials on safety and efficacy of video-Assisted thoracic surgery lobectomy for early-Stage non- small-cell lung cancer. J Clin Oncol, 2009,27:2553 - 2562.
  • 9Petersen RP, Pham D, Burfeind WR, et al. Thoracoscopic lobeetomy facilitates the delivery of chemotherapy 'after resection for lung cancer. Ann Thorac Surg,2007,83 : 1245 - 1249.
  • 10Mun M, Kohno T. Video-assisted thoracic surgery for clinical stage I lung cancer in octogenarians. Ann Thorae Surg,2008 ,85 :406 -411.

共引文献157

同被引文献132

  • 1傅成国,姜杰,高惠川,康健乐,吴朝辉.胸腔镜辅助小切口解剖肺叶及全肺切除术的临床研究[J].中国微创外科杂志,2008,8(3):241-242. 被引量:10
  • 2王俊.电视胸腔镜在胸部疾病治疗中的应用现状[J].临床外科杂志,2005,13(6):384-385. 被引量:82
  • 3Roviaro G, Rebuffat C, Varoli F, et al. Videoendoscopic pulmonary lobectomy for cancer [J]. Surg Laparosc Endosc, 1992,2(3) : 244-247.
  • 4Mckenna RJ, Houch W, Fuller CB. Video-assisted thoracic surgery lobectomy: Experience with 1100 cases [J]. Ann Thorac Surg, 2006,81(2) :421-426.
  • 5NCCN Clinical Practice Guidelines in Oncology[EB/OL]. http: //www.nccn.org/clinical.asp.
  • 6Seder CW, Hanna K, Lucia V, et al. The safe transition from open to thoracoscopic lobectomy: A 5-year experience [J]. Ann Thorac Surg, 2009,88( 1 ) : 216-225.
  • 7Demmy TL, Curtis JJ. Minimally invasive lobectomy directed toward frail and high-risk patients: A case-control study [J]. Ann Thorac Surg, 1999,68(1) : 194-200.
  • 8Li WW, Lee RL, Lee TW, et al. The impact of thoracic surgical access on early shoulder function: Video-assisted thoracic surgery versus posterolateral thoraeotomy [J]. Eur J Cardiothorac Surg, 2003,23 (3) : 390-396.
  • 9Ng CSH, Lee TW, Wan S, et al. Thoracotomy is associated with significantly more profound suppression in lymphocytes andnatural killer cells than video-assisted thoracic surgery following major lung resections for cancer [J]. J Invest Surg, 2005,18 (2) :81-88.
  • 10Jizasa T, Fujisawa T, Suzuki M, et al. Elevated levels of circulating plasma matrix metalloproteinase 9 in non-small cell lung cancer patients [J]. Clin Cancer Res, 1999,5 (1) : 149- 153.

引证文献14

二级引证文献185

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部